Paramagnetic rim lesions on MRI brain scans were highly specific in differentiating MS from non-MS in patients with neurological conditions.
In patients with multiple sclerosis (MS), some chronic active white matter lesions leave a persistent dark rim of inflammation after acute inflammation subsides. These paramagnetic rim lesions (PRLs) are identifiable by MRI and are thought to represent macrophage infiltration and microglia activation.
To determine the potential role for PRLs in the differential diagnosis of MS, investigators conducted an international, cross-sectional study of 412 neurology patients, of whom 329 had MS and 83 had other neurological conditions. The researchers performed MRI brain scans on patients using three Tesla MRI scanners at five centers and reported the specificity of PRL alone or in combination with the central vein sign marker in diagnosing MS versus…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)